There is a lower risk of 1-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator (ICD) compared with men.

LONDON--(BUSINESS WIRE)--Technavio’s global implantable cardioverter defibrillators (ICD) market research report forecasts the market to grow at a CAGR of almost 2% during the forecast period. The ...

MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta™ portfolio of implantable cardioverter-defibrillators (ICDs) ...

The FDA has issued a safety alert for several models of Boston Scientific’s Endotak Reliance defibrillation leads after identifying a serious defect linked to 16 deaths and 386 injuries. The leads, ...

Almost exactly a year after beginning a recall of some of its implantable defibrillator devices that were found to potentially emit electrical pulses below their programmed strength, Medtronic has ...

BALTIMORE (AP) - Dr. Morton Mower, a former Maryland-based cardiologist who helped invent an automatic implantable defibrillator that has helped countless heart patients live longer and healthier, has ...

Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...

The researchers found that women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator had a lower risk for ventricular tachyarrhythmias or death compared to men. HealthDay ...